More recently, urine NGAL has been shown to be elevated in patients with chronic tubulointerstitial disease [17, 18] and urine NGAL may be predictive of long term decline in renal function in nonproteinuric CKD, but limited data are available in glomerular diseases. This evidence concerns the gene LCN2 and chronic kidney disease.